Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pallvi Kumari
Observed name:
Pallvi Kumari
Institution:
CT University
Observed institution:
CT University
ORCID:
0009-0005-0101-1064
Observed ORCID:
0009-0005-0101-1064
OpenAlex ID:
A5126355359
Coumarin-based hybrid compounds: A new approach to cancer therapy
2025
·
Pallvi Kumari
, Manpreet Kaur
·
Journal of Molecular Structure
·
10
PROTAC approaches against drug-resistant EGFR C797S/L858R/T790M mutants: biological evaluation and SAR studies (2020–2025)
2026
·
Ankush Kumar
, Vishakha Sharma
, et al.
·
RSC Medicinal Chemistry
·
6
PDF
Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies
2026
·
Bishal Singh
, Dilpreet Singh
, et al.
·
International Immunopharmacology
·
4
para-aminobenzoic acid hybrids as potential anticancer agents
2026
·
Pallvi Kumari
, Deepika Kumari
·
Journal of Molecular Structure
·
1
Ingestible smart capsules: from engineering innovation to GI drug delivery
2026
·
Dilpreet Singh
, Pallvi Kumari
, et al.
·
Biomedical Microdevices
·
1
Sustainable Synthesis of Pyrazole Derivatives: Recent Advances in Anticancer Drug Discovery
2026
·
Akshay Kumar
, Shreya Chauhan
, et al.
·
Synlett
Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation
2026
·
Anurag Biswas
, Bijoy Ghosh
, et al.
·
DARU Journal of Pharmaceutical Sciences
Surface-engineered nanocellulose for enhanced antibacterial activity and biomedical applications
2026
·
Pallvi Kumari
, Dilpreet Singh
, et al.
·
Carbohydrate Research
Hybrid molecules of six-membered heterocycles (piperazine, pyran, pyrazine): Structure activity insights against multiple cancers
2026
·
Pallvi Kumari
, Akshay Thakur
·
Chemistry of Heterocyclic Compounds
Light microscopic dataset of angiosperm pollen diversity from Sirmaur district, Himachal Pradesh (India)
2026
·
Rubal Kumari
, Devendra Kumar Srivastava
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Common Drug-Drug Interactions
2026
·
Suman Lata
, Pallvi Kumari
, et al.
·
BENTHAM SCIENCE PUBLISHERS eBooks
Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction
2026
·
Ankush Kumar
, Pallvi Kumari
, et al.
·
Archiv der Pharmazie
Author response for "PROTAC Approaches against Drug-Resistant EGFRC797S/L858R/T790M Mutants: Biological Evaluation and SAR Studies (2020-2025)"
2026
·
Ankush Kumar
, Vishakha Sharma
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
13
Citation count:
22
H-index:
3
I10-index:
1
Year
Topic
Type
